Review



mbc mic50 mic90 mic range mbc range mpall  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 96
      Buy from Supplier

    Structured Review

    ATCC mbc mic50 mic90 mic range mbc range mpall
    Mbc Mic50 Mic90 Mic Range Mbc Range Mpall, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 711 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mic90+range/Auricularia+fuscosuccinea+(Montagne)+Farlow%2C+teleomorph/pm37570659-88-16-7
    Average 96 stars, based on 711 article reviews
    mbc mic50 mic90 mic range mbc range mpall - by Bioz Stars, 2026-10
    96/100 stars

    Images

    Related Articles

    In Vitro:

    Article Title: Efficacy and Safety of PL-5 (Peceleganan) Spray for Wound Infections
    Article Snippet: Antibacterial effect of antimicrobial peptide PL-5 and imipenem cilastatin sodium on Escherichia coli in vitro Sample Bacteria Strains NO. of Strains Strains of bacteria not growing under different drug concentrations (μg/ml) MIC range (μg/ml) MIC50 (μg/ml) MIC90 (μg/ml) MIC Geometric mean (μg/ml) 64 32 16 8 4 2 1 1/2 1/4 1/8 solvent Culture medium PL-5 ESBLs E. Coli (ATCC 35218) 1 1 1 1 1 1 0 0 0 - - 0 1 4 4 4 4 Non-ESBLs E. Coli ( ATCC 25922) 1 1 1 1 1 1 0 0 0 - - 0 1 4 4 4 4 ESBLs E. Coli 79 74 73 71 70 61 23 0 0 - - 0 79 2~>64 4 32 4.68 Non-ESBLs E. Coli 40 37 33 33 33 18 2 0 0 - - 0 40 2~>64 8 64 8.14 imipenem cilastatin sodium ESBLs E. Coli (ATCC 35218) 1 - - 1 1 1 1 1 1 1 0 0 1 0.25 0.25 0.25 0.25 Non-ESBLs E. Coli (ATCC 25922) 1 - 1 1 1 1 1 1 1 1 0 0 1 0.25 0.25 0.25 0.25 ESBLs E. Coli 79 - 77 77 73 73 61 54 47 30 2 0 79 <0.125~>32 0.5 4 0.84 Non-ESBLs E. Coli 40 - 40 40 40 40 40 39 33 21 0 0 40 0.25~2 0.25 1 0.39 Bactericidal effect of antimicrobial peptide PL-5 and imipenem cilastatin sodium on Escherichia coli in vitro Sample Bacteria Strains Number of Strains Strains of bacteria not growing under different drug concentrations (μg/ml) MBC range (μg/ml) MBC50 (μg/ml) MBC90 (μg/ml) 64 32 16 8 4 2 1 1/2 1/4 1/8 Solvent Culture medium PL-5 ESBLs E. Coli (ATCC 35218) 1 1 1 1 1 1 0 0 0 - 0 0 1 4 4 4 Non-ESBLs E. Coli (ATCC 25922) 1 1 1 1 1 1 0 0 0 - 0 0 1 4 4 4 ESBLs E. Coli 79 74 70 62 50 40 13 0 0 - 0 0 79 2~>64 4 64 Non-ESBLs E. Coli 40 35 32 30 25 10 1 0 0 - 0 0 40 2~>64 8 >64 imipenem cilastatin sodium ESBLs E. Coli (ATCC 35218) 1 - - 1 1 0 0 0 0 0 0 0 1 8 8 8 Non-ESBLs E. Coli (ATCC 25922) 1 - - 94 81 1 1 1 1 0 0 0 1 0.5 0.5 0.5 ESBLs E. Coloi 79 - - 94 81 61 46 37 23 12 1 0 79 <0.125~>16 2 >16 Non-ESBLs E. Coli 40 - - 89 77 12 12 8 3 1 0 0 40 0.25~>16 16 >16 Cumulative antibacterial percentage of antimicrobial peptide PL-5 and imipenem cilastatin sodium on .. Antibacterial effect of antimicrobial peptide PL-5 and imipenem cilastatin sodium on Escherichia coli in vitro Sample Bacteria Strains NO. of Strains Strains of bacteria not growing under different drug concentrations (μg/ml) MIC range (μg/ml) MIC50 (μg/ml) MIC90 (μg/ml) MIC Geometric mean (μg/ml) 64 32 16 8 4 2 1 1/2 1/4 1/8 solvent Culture medium PL-5 ESBLs E. Coli (ATCC 35218) 1 1 1 1 1 1 0 0 0 - - 0 1 4 4 4 4 Non-ESBLs E. Coli ( ATCC 25922) 1 1 1 1 1 1 0 0 0 - - 0 1 4 4 4 4 ESBLs E. Coli 79 74 73 71 70 61 23 0 0 - - 0 79 2~>64 4 32 4.68 Non-ESBLs E. Coli 40 37 33 33 33 18 2 0 0 - - 0 40 2~>64 8 64 8.14 imipenem cilastatin sodium ESBLs E. Coli (ATCC 35218) 1 - - 1 1 1 1 1 1 1 0 0 1 0.25 0.25 0.25 0.25 Non-ESBLs E. Coli (ATCC 25922) 1 - 1 1 1 1 1 1 1 1 0 0 1 0.25 0.25 0.25 0.25 ESBLs E. Coli 79 - 77 77 73 73 61 54 47 30 2 0 79 <0.125~>32 0.5 4 0.84 Non-ESBLs E. Coli 40 - 40 40 40 40 40 39 33 21 0 0 40 0.25~2 0.25 1 0.39 Bactericidal effect of antimicrobial peptide PL-5 and imipenem cilastatin sodium on Escherichia coli in vitro Sample Bacteria Strains Number of Strains Strains of bacteria not growing under different drug concentrations (μg/ml) MBC range (μg/ml) MBC50 (μg/ml) MBC90 (μg/ml) 64 32 16 8 4 2 1 1/2 1/4 1/8 Solvent Culture medium PL-5 ESBLs E. Coli (ATCC 35218) 1 1 1 1 1 1 0 0 0 - 0 0 1 4 4 4 Non-ESBLs E. Coli (ATCC 25922) 1 1 1 1 1 1 0 0 0 - 0 0 1 4 4 4 ESBLs E. Coli 79 74 70 62 50 40 13 0 0 - 0 0 79 2~>64 4 64 Non-ESBLs E. Coli 40 35 32 30 25 10 1 0 0 - 0 0 40 2~>64 8 >64 imipenem cilastatin sodium ESBLs E. Coli (ATCC 35218) 1 - - 1 1 0 0 0 0 0 0 0 1 8 8 8 Non-ESBLs E. Coli (ATCC 25922) 1 - - 94 81 1 1 1 1 0 0 0 1 0.5 0.5 0.5 ESBLs E. Coloi 79 - - 94 81 61 46 37 23 12 1 0 79 <0.125~>16 2 >16 Non-ESBLs E. Coli 40 - - 89 77 12 12 8 3 1 0 0 40 0.25~>16 16 >16 Cumulative antibacterial percentage of antimicrobial peptide PL-5 and imipenem cilastatin sodium on ..

    Article Title: Efficacy and Safety of PL-5 (Peceleganan) Spray for Wound Infections
    Article Snippet: .. Antibacterial effect of antimicrobial peptide PL-5 and vancomycin on Enterococcus faecalis and Enterococcus faecium in vitro Sample Bacteria Strains Number of Strains Strains of bacteria not growing under different drug concentrations (μg/ml) MIC range (μg/ml) MIC50 (μg/ml) MIC90 (μg/ml) MIC Geometric mean (μg/ml) 64 32 16 8 4 2 1 1/2 1/4 solvent Culture medium PL-5 Enterococcus faecalis (ATCC 29212) 1 1 1 0 0 0 0 0 0 - 0 1 32 32 32 32 Enterococcus faecalis 40 32 26 22 19 17 3 0 0 - 0 40 2~>64 16 >64 14.17 Enterococcus faecium 40 37 29 25 22 21 3 0 0 - 0 40 2~>64 4 64 11.31 Vancomycin Enterococcus faecalis (ATCC 29212) 1 - 1 1 1 1 1 1 0 0 0 1 1 1 1 1 Enterococcus faecalis 40 - 40 40 40 40 40 39 23 0 0 40 0.5~2 0.5 1 0.68 Enterococcus faecium 40 - 32 32 32 32 32 26 15 0 0 40 0.5 ~ 32 1 >32 1.71 Bactericidal effect of antimicrobial peptide PL-5 and vancomycin on Enterococcus faecalis and Enterococcus faecium in vitro Sample Bacteria Strains Number of Strains Strains of bacteria not growing under different drug concentrations (μg/ml) MBC range (μg/ml) MBC50 (μg/ml) MBC90 (μg/ml) 64 32 16 8 4 2 1 1/2 1/4 solvent Culture medium PL-5 Enterococcus faecalis (ATCC 29212) 1 1 1 0 0 0 0 0 0 - 0 1 32 32 32 Enterococcus faecalis 40 31 25 22 16 4 1 0 0 - 0 40 2~>64 16 >64 Enterococcus faecium 40 34 27 22 19 10 1 0 0 - 0 40 2~>64 16 >64 Vancomycin Enterococcus faecalis (ATCC 29212) 1 - 0 0 0 0 0 0 0 0 0 1 >32 >32 >32 Enterococcus faecalis 40 - 33 10 3 0 0 0 0 0 0 40 8~>32 32 >32 Enterococcus faecium 40 - 20 4 0 0 0 0 0 0 0 40 16~>32 32 >32 Cumulative antibacterial percentage of antimicrobial peptide PL-5 and vancomycin on Enterococcus faecalis and Enterococcus faecium in vitro Sample Bacteria Strains Number of Strains Cumulative antibacterial percentage of different concentrations (μg/ml) of tested drugs (%) MBC50/MIC50 MBC90/MIC90 64 32 16 8 4 2 1 0.5 0.25 PL-5 Enterococcus faecalis 40 80 65 55 48 43 8 0 0 - 1 - Enterococcus faecium 40 93 73 63 55 53 8 0 0 - 4 >1 Vancomycin Enterococcus faecalis 40 - 100 100 100 100 100 98 58 0 64 >32 Enterococcus faecium 40 - 80 80 80 80 80 65 38 0 32 - Cumulative bactericidal percentage of antimicrobial peptide PL-5 and vancomycin on Enterococcus faecalis and Enterococcus faecium in vitro Sample Bacteria Strains Number of Strains Cumulative bactericidal percentage of different concentrations (μg/ml) of tested drugs (%) 64 32 16 8 4 2 1 0.5 0.25 PL-5 Enterococcus faecalis 40 78 63 55 40 14 10 3 0 - Enterococcus faecium 40 85 68 55 48 25 25 3 0 - Vancomycin Enterococcus faecalis 40 - 83 25 8 100 0 0 0 0 Enterococcus faecium 40 - 50 10 0 55 0 0 0 0 4. ..

    Bacteria:

    Article Title: Efficacy and Safety of PL-5 (Peceleganan) Spray for Wound Infections
    Article Snippet: Antibacterial effect of antimicrobial peptide PL-5 and imipenem cilastatin sodium on Escherichia coli in vitro Sample Bacteria Strains NO. of Strains Strains of bacteria not growing under different drug concentrations (μg/ml) MIC range (μg/ml) MIC50 (μg/ml) MIC90 (μg/ml) MIC Geometric mean (μg/ml) 64 32 16 8 4 2 1 1/2 1/4 1/8 solvent Culture medium PL-5 ESBLs E. Coli (ATCC 35218) 1 1 1 1 1 1 0 0 0 - - 0 1 4 4 4 4 Non-ESBLs E. Coli ( ATCC 25922) 1 1 1 1 1 1 0 0 0 - - 0 1 4 4 4 4 ESBLs E. Coli 79 74 73 71 70 61 23 0 0 - - 0 79 2~>64 4 32 4.68 Non-ESBLs E. Coli 40 37 33 33 33 18 2 0 0 - - 0 40 2~>64 8 64 8.14 imipenem cilastatin sodium ESBLs E. Coli (ATCC 35218) 1 - - 1 1 1 1 1 1 1 0 0 1 0.25 0.25 0.25 0.25 Non-ESBLs E. Coli (ATCC 25922) 1 - 1 1 1 1 1 1 1 1 0 0 1 0.25 0.25 0.25 0.25 ESBLs E. Coli 79 - 77 77 73 73 61 54 47 30 2 0 79 <0.125~>32 0.5 4 0.84 Non-ESBLs E. Coli 40 - 40 40 40 40 40 39 33 21 0 0 40 0.25~2 0.25 1 0.39 Bactericidal effect of antimicrobial peptide PL-5 and imipenem cilastatin sodium on Escherichia coli in vitro Sample Bacteria Strains Number of Strains Strains of bacteria not growing under different drug concentrations (μg/ml) MBC range (μg/ml) MBC50 (μg/ml) MBC90 (μg/ml) 64 32 16 8 4 2 1 1/2 1/4 1/8 Solvent Culture medium PL-5 ESBLs E. Coli (ATCC 35218) 1 1 1 1 1 1 0 0 0 - 0 0 1 4 4 4 Non-ESBLs E. Coli (ATCC 25922) 1 1 1 1 1 1 0 0 0 - 0 0 1 4 4 4 ESBLs E. Coli 79 74 70 62 50 40 13 0 0 - 0 0 79 2~>64 4 64 Non-ESBLs E. Coli 40 35 32 30 25 10 1 0 0 - 0 0 40 2~>64 8 >64 imipenem cilastatin sodium ESBLs E. Coli (ATCC 35218) 1 - - 1 1 0 0 0 0 0 0 0 1 8 8 8 Non-ESBLs E. Coli (ATCC 25922) 1 - - 94 81 1 1 1 1 0 0 0 1 0.5 0.5 0.5 ESBLs E. Coloi 79 - - 94 81 61 46 37 23 12 1 0 79 <0.125~>16 2 >16 Non-ESBLs E. Coli 40 - - 89 77 12 12 8 3 1 0 0 40 0.25~>16 16 >16 Cumulative antibacterial percentage of antimicrobial peptide PL-5 and imipenem cilastatin sodium on .. Antibacterial effect of antimicrobial peptide PL-5 and imipenem cilastatin sodium on Escherichia coli in vitro Sample Bacteria Strains NO. of Strains Strains of bacteria not growing under different drug concentrations (μg/ml) MIC range (μg/ml) MIC50 (μg/ml) MIC90 (μg/ml) MIC Geometric mean (μg/ml) 64 32 16 8 4 2 1 1/2 1/4 1/8 solvent Culture medium PL-5 ESBLs E. Coli (ATCC 35218) 1 1 1 1 1 1 0 0 0 - - 0 1 4 4 4 4 Non-ESBLs E. Coli ( ATCC 25922) 1 1 1 1 1 1 0 0 0 - - 0 1 4 4 4 4 ESBLs E. Coli 79 74 73 71 70 61 23 0 0 - - 0 79 2~>64 4 32 4.68 Non-ESBLs E. Coli 40 37 33 33 33 18 2 0 0 - - 0 40 2~>64 8 64 8.14 imipenem cilastatin sodium ESBLs E. Coli (ATCC 35218) 1 - - 1 1 1 1 1 1 1 0 0 1 0.25 0.25 0.25 0.25 Non-ESBLs E. Coli (ATCC 25922) 1 - 1 1 1 1 1 1 1 1 0 0 1 0.25 0.25 0.25 0.25 ESBLs E. Coli 79 - 77 77 73 73 61 54 47 30 2 0 79 <0.125~>32 0.5 4 0.84 Non-ESBLs E. Coli 40 - 40 40 40 40 40 39 33 21 0 0 40 0.25~2 0.25 1 0.39 Bactericidal effect of antimicrobial peptide PL-5 and imipenem cilastatin sodium on Escherichia coli in vitro Sample Bacteria Strains Number of Strains Strains of bacteria not growing under different drug concentrations (μg/ml) MBC range (μg/ml) MBC50 (μg/ml) MBC90 (μg/ml) 64 32 16 8 4 2 1 1/2 1/4 1/8 Solvent Culture medium PL-5 ESBLs E. Coli (ATCC 35218) 1 1 1 1 1 1 0 0 0 - 0 0 1 4 4 4 Non-ESBLs E. Coli (ATCC 25922) 1 1 1 1 1 1 0 0 0 - 0 0 1 4 4 4 ESBLs E. Coli 79 74 70 62 50 40 13 0 0 - 0 0 79 2~>64 4 64 Non-ESBLs E. Coli 40 35 32 30 25 10 1 0 0 - 0 0 40 2~>64 8 >64 imipenem cilastatin sodium ESBLs E. Coli (ATCC 35218) 1 - - 1 1 0 0 0 0 0 0 0 1 8 8 8 Non-ESBLs E. Coli (ATCC 25922) 1 - - 94 81 1 1 1 1 0 0 0 1 0.5 0.5 0.5 ESBLs E. Coloi 79 - - 94 81 61 46 37 23 12 1 0 79 <0.125~>16 2 >16 Non-ESBLs E. Coli 40 - - 89 77 12 12 8 3 1 0 0 40 0.25~>16 16 >16 Cumulative antibacterial percentage of antimicrobial peptide PL-5 and imipenem cilastatin sodium on ..

    Article Title: Efficacy and Safety of PL-5 (Peceleganan) Spray for Wound Infections
    Article Snippet: .. Antibacterial effect of antimicrobial peptide PL-5 and vancomycin on Enterococcus faecalis and Enterococcus faecium in vitro Sample Bacteria Strains Number of Strains Strains of bacteria not growing under different drug concentrations (μg/ml) MIC range (μg/ml) MIC50 (μg/ml) MIC90 (μg/ml) MIC Geometric mean (μg/ml) 64 32 16 8 4 2 1 1/2 1/4 solvent Culture medium PL-5 Enterococcus faecalis (ATCC 29212) 1 1 1 0 0 0 0 0 0 - 0 1 32 32 32 32 Enterococcus faecalis 40 32 26 22 19 17 3 0 0 - 0 40 2~>64 16 >64 14.17 Enterococcus faecium 40 37 29 25 22 21 3 0 0 - 0 40 2~>64 4 64 11.31 Vancomycin Enterococcus faecalis (ATCC 29212) 1 - 1 1 1 1 1 1 0 0 0 1 1 1 1 1 Enterococcus faecalis 40 - 40 40 40 40 40 39 23 0 0 40 0.5~2 0.5 1 0.68 Enterococcus faecium 40 - 32 32 32 32 32 26 15 0 0 40 0.5 ~ 32 1 >32 1.71 Bactericidal effect of antimicrobial peptide PL-5 and vancomycin on Enterococcus faecalis and Enterococcus faecium in vitro Sample Bacteria Strains Number of Strains Strains of bacteria not growing under different drug concentrations (μg/ml) MBC range (μg/ml) MBC50 (μg/ml) MBC90 (μg/ml) 64 32 16 8 4 2 1 1/2 1/4 solvent Culture medium PL-5 Enterococcus faecalis (ATCC 29212) 1 1 1 0 0 0 0 0 0 - 0 1 32 32 32 Enterococcus faecalis 40 31 25 22 16 4 1 0 0 - 0 40 2~>64 16 >64 Enterococcus faecium 40 34 27 22 19 10 1 0 0 - 0 40 2~>64 16 >64 Vancomycin Enterococcus faecalis (ATCC 29212) 1 - 0 0 0 0 0 0 0 0 0 1 >32 >32 >32 Enterococcus faecalis 40 - 33 10 3 0 0 0 0 0 0 40 8~>32 32 >32 Enterococcus faecium 40 - 20 4 0 0 0 0 0 0 0 40 16~>32 32 >32 Cumulative antibacterial percentage of antimicrobial peptide PL-5 and vancomycin on Enterococcus faecalis and Enterococcus faecium in vitro Sample Bacteria Strains Number of Strains Cumulative antibacterial percentage of different concentrations (μg/ml) of tested drugs (%) MBC50/MIC50 MBC90/MIC90 64 32 16 8 4 2 1 0.5 0.25 PL-5 Enterococcus faecalis 40 80 65 55 48 43 8 0 0 - 1 - Enterococcus faecium 40 93 73 63 55 53 8 0 0 - 4 >1 Vancomycin Enterococcus faecalis 40 - 100 100 100 100 100 98 58 0 64 >32 Enterococcus faecium 40 - 80 80 80 80 80 65 38 0 32 - Cumulative bactericidal percentage of antimicrobial peptide PL-5 and vancomycin on Enterococcus faecalis and Enterococcus faecium in vitro Sample Bacteria Strains Number of Strains Cumulative bactericidal percentage of different concentrations (μg/ml) of tested drugs (%) 64 32 16 8 4 2 1 0.5 0.25 PL-5 Enterococcus faecalis 40 78 63 55 40 14 10 3 0 - Enterococcus faecium 40 85 68 55 48 25 25 3 0 - Vancomycin Enterococcus faecalis 40 - 83 25 8 100 0 0 0 0 Enterococcus faecium 40 - 50 10 0 55 0 0 0 0 4. ..

    Solvent:

    Article Title: Efficacy and Safety of PL-5 (Peceleganan) Spray for Wound Infections
    Article Snippet: Antibacterial effect of antimicrobial peptide PL-5 and imipenem cilastatin sodium on Escherichia coli in vitro Sample Bacteria Strains NO. of Strains Strains of bacteria not growing under different drug concentrations (μg/ml) MIC range (μg/ml) MIC50 (μg/ml) MIC90 (μg/ml) MIC Geometric mean (μg/ml) 64 32 16 8 4 2 1 1/2 1/4 1/8 solvent Culture medium PL-5 ESBLs E. Coli (ATCC 35218) 1 1 1 1 1 1 0 0 0 - - 0 1 4 4 4 4 Non-ESBLs E. Coli ( ATCC 25922) 1 1 1 1 1 1 0 0 0 - - 0 1 4 4 4 4 ESBLs E. Coli 79 74 73 71 70 61 23 0 0 - - 0 79 2~>64 4 32 4.68 Non-ESBLs E. Coli 40 37 33 33 33 18 2 0 0 - - 0 40 2~>64 8 64 8.14 imipenem cilastatin sodium ESBLs E. Coli (ATCC 35218) 1 - - 1 1 1 1 1 1 1 0 0 1 0.25 0.25 0.25 0.25 Non-ESBLs E. Coli (ATCC 25922) 1 - 1 1 1 1 1 1 1 1 0 0 1 0.25 0.25 0.25 0.25 ESBLs E. Coli 79 - 77 77 73 73 61 54 47 30 2 0 79 <0.125~>32 0.5 4 0.84 Non-ESBLs E. Coli 40 - 40 40 40 40 40 39 33 21 0 0 40 0.25~2 0.25 1 0.39 Bactericidal effect of antimicrobial peptide PL-5 and imipenem cilastatin sodium on Escherichia coli in vitro Sample Bacteria Strains Number of Strains Strains of bacteria not growing under different drug concentrations (μg/ml) MBC range (μg/ml) MBC50 (μg/ml) MBC90 (μg/ml) 64 32 16 8 4 2 1 1/2 1/4 1/8 Solvent Culture medium PL-5 ESBLs E. Coli (ATCC 35218) 1 1 1 1 1 1 0 0 0 - 0 0 1 4 4 4 Non-ESBLs E. Coli (ATCC 25922) 1 1 1 1 1 1 0 0 0 - 0 0 1 4 4 4 ESBLs E. Coli 79 74 70 62 50 40 13 0 0 - 0 0 79 2~>64 4 64 Non-ESBLs E. Coli 40 35 32 30 25 10 1 0 0 - 0 0 40 2~>64 8 >64 imipenem cilastatin sodium ESBLs E. Coli (ATCC 35218) 1 - - 1 1 0 0 0 0 0 0 0 1 8 8 8 Non-ESBLs E. Coli (ATCC 25922) 1 - - 94 81 1 1 1 1 0 0 0 1 0.5 0.5 0.5 ESBLs E. Coloi 79 - - 94 81 61 46 37 23 12 1 0 79 <0.125~>16 2 >16 Non-ESBLs E. Coli 40 - - 89 77 12 12 8 3 1 0 0 40 0.25~>16 16 >16 Cumulative antibacterial percentage of antimicrobial peptide PL-5 and imipenem cilastatin sodium on .. Antibacterial effect of antimicrobial peptide PL-5 and imipenem cilastatin sodium on Escherichia coli in vitro Sample Bacteria Strains NO. of Strains Strains of bacteria not growing under different drug concentrations (μg/ml) MIC range (μg/ml) MIC50 (μg/ml) MIC90 (μg/ml) MIC Geometric mean (μg/ml) 64 32 16 8 4 2 1 1/2 1/4 1/8 solvent Culture medium PL-5 ESBLs E. Coli (ATCC 35218) 1 1 1 1 1 1 0 0 0 - - 0 1 4 4 4 4 Non-ESBLs E. Coli ( ATCC 25922) 1 1 1 1 1 1 0 0 0 - - 0 1 4 4 4 4 ESBLs E. Coli 79 74 73 71 70 61 23 0 0 - - 0 79 2~>64 4 32 4.68 Non-ESBLs E. Coli 40 37 33 33 33 18 2 0 0 - - 0 40 2~>64 8 64 8.14 imipenem cilastatin sodium ESBLs E. Coli (ATCC 35218) 1 - - 1 1 1 1 1 1 1 0 0 1 0.25 0.25 0.25 0.25 Non-ESBLs E. Coli (ATCC 25922) 1 - 1 1 1 1 1 1 1 1 0 0 1 0.25 0.25 0.25 0.25 ESBLs E. Coli 79 - 77 77 73 73 61 54 47 30 2 0 79 <0.125~>32 0.5 4 0.84 Non-ESBLs E. Coli 40 - 40 40 40 40 40 39 33 21 0 0 40 0.25~2 0.25 1 0.39 Bactericidal effect of antimicrobial peptide PL-5 and imipenem cilastatin sodium on Escherichia coli in vitro Sample Bacteria Strains Number of Strains Strains of bacteria not growing under different drug concentrations (μg/ml) MBC range (μg/ml) MBC50 (μg/ml) MBC90 (μg/ml) 64 32 16 8 4 2 1 1/2 1/4 1/8 Solvent Culture medium PL-5 ESBLs E. Coli (ATCC 35218) 1 1 1 1 1 1 0 0 0 - 0 0 1 4 4 4 Non-ESBLs E. Coli (ATCC 25922) 1 1 1 1 1 1 0 0 0 - 0 0 1 4 4 4 ESBLs E. Coli 79 74 70 62 50 40 13 0 0 - 0 0 79 2~>64 4 64 Non-ESBLs E. Coli 40 35 32 30 25 10 1 0 0 - 0 0 40 2~>64 8 >64 imipenem cilastatin sodium ESBLs E. Coli (ATCC 35218) 1 - - 1 1 0 0 0 0 0 0 0 1 8 8 8 Non-ESBLs E. Coli (ATCC 25922) 1 - - 94 81 1 1 1 1 0 0 0 1 0.5 0.5 0.5 ESBLs E. Coloi 79 - - 94 81 61 46 37 23 12 1 0 79 <0.125~>16 2 >16 Non-ESBLs E. Coli 40 - - 89 77 12 12 8 3 1 0 0 40 0.25~>16 16 >16 Cumulative antibacterial percentage of antimicrobial peptide PL-5 and imipenem cilastatin sodium on ..

    Article Title: Efficacy and Safety of PL-5 (Peceleganan) Spray for Wound Infections
    Article Snippet: .. Antibacterial effect of antimicrobial peptide PL-5 and vancomycin on Enterococcus faecalis and Enterococcus faecium in vitro Sample Bacteria Strains Number of Strains Strains of bacteria not growing under different drug concentrations (μg/ml) MIC range (μg/ml) MIC50 (μg/ml) MIC90 (μg/ml) MIC Geometric mean (μg/ml) 64 32 16 8 4 2 1 1/2 1/4 solvent Culture medium PL-5 Enterococcus faecalis (ATCC 29212) 1 1 1 0 0 0 0 0 0 - 0 1 32 32 32 32 Enterococcus faecalis 40 32 26 22 19 17 3 0 0 - 0 40 2~>64 16 >64 14.17 Enterococcus faecium 40 37 29 25 22 21 3 0 0 - 0 40 2~>64 4 64 11.31 Vancomycin Enterococcus faecalis (ATCC 29212) 1 - 1 1 1 1 1 1 0 0 0 1 1 1 1 1 Enterococcus faecalis 40 - 40 40 40 40 40 39 23 0 0 40 0.5~2 0.5 1 0.68 Enterococcus faecium 40 - 32 32 32 32 32 26 15 0 0 40 0.5 ~ 32 1 >32 1.71 Bactericidal effect of antimicrobial peptide PL-5 and vancomycin on Enterococcus faecalis and Enterococcus faecium in vitro Sample Bacteria Strains Number of Strains Strains of bacteria not growing under different drug concentrations (μg/ml) MBC range (μg/ml) MBC50 (μg/ml) MBC90 (μg/ml) 64 32 16 8 4 2 1 1/2 1/4 solvent Culture medium PL-5 Enterococcus faecalis (ATCC 29212) 1 1 1 0 0 0 0 0 0 - 0 1 32 32 32 Enterococcus faecalis 40 31 25 22 16 4 1 0 0 - 0 40 2~>64 16 >64 Enterococcus faecium 40 34 27 22 19 10 1 0 0 - 0 40 2~>64 16 >64 Vancomycin Enterococcus faecalis (ATCC 29212) 1 - 0 0 0 0 0 0 0 0 0 1 >32 >32 >32 Enterococcus faecalis 40 - 33 10 3 0 0 0 0 0 0 40 8~>32 32 >32 Enterococcus faecium 40 - 20 4 0 0 0 0 0 0 0 40 16~>32 32 >32 Cumulative antibacterial percentage of antimicrobial peptide PL-5 and vancomycin on Enterococcus faecalis and Enterococcus faecium in vitro Sample Bacteria Strains Number of Strains Cumulative antibacterial percentage of different concentrations (μg/ml) of tested drugs (%) MBC50/MIC50 MBC90/MIC90 64 32 16 8 4 2 1 0.5 0.25 PL-5 Enterococcus faecalis 40 80 65 55 48 43 8 0 0 - 1 - Enterococcus faecium 40 93 73 63 55 53 8 0 0 - 4 >1 Vancomycin Enterococcus faecalis 40 - 100 100 100 100 100 98 58 0 64 >32 Enterococcus faecium 40 - 80 80 80 80 80 65 38 0 32 - Cumulative bactericidal percentage of antimicrobial peptide PL-5 and vancomycin on Enterococcus faecalis and Enterococcus faecium in vitro Sample Bacteria Strains Number of Strains Cumulative bactericidal percentage of different concentrations (μg/ml) of tested drugs (%) 64 32 16 8 4 2 1 0.5 0.25 PL-5 Enterococcus faecalis 40 78 63 55 40 14 10 3 0 - Enterococcus faecium 40 85 68 55 48 25 25 3 0 - Vancomycin Enterococcus faecalis 40 - 83 25 8 100 0 0 0 0 Enterococcus faecium 40 - 50 10 0 55 0 0 0 0 4. ..

    Concentration Assay:

    Article Title: Composition and Anti- Helicobacter pylori Properties of Essential Oils Obtained from Selected Mentha Cultivars.
    Article Snippet: .. Mint EOs and Reference Compounds Helicobacter pylori ATCC 43504 Clinical Helicobacter pylori Strains mg/L MIC * MBC MIC50 MIC90 MIC Range MBC Range MpAlL 15.6 15.6 125 125 62.5–250 15.6–250 MpGrL 31.3 31.3 125 250 62.5–250 31.3–250 MpGrF 31.3 125 250 250 125–500 31.3–500 MpMmL 31.3 31.3 62.5 125 62.5–250 31.3–250 MpMmF 31.3 31.3 250 500 250–500 31.3–1000 MpSwL 15.6 62.5 31.3 125 31.3–125 31.3–125 MpSwF 15.6 62.5 250 500 125–500 62.5–500 MsMoL 31.3 31.3 62.5 62.5 31.3–125 31.3–125 MsMoF 15.6 15.6 62.5 62.5 31.3–125 15.6–125 Menthol 62.5 250 7.8 31.3 7.8–31.3 7.8–250 Menthone 250 250 1000 1000 250–>1000 250–>1000 Linalool 125 250 125 250 62.5–500 62.5–500 1,8-Cineole 125 250 >1000 >1000 >1000 250–>1000 Limonene 62.5 125 500 1000 250–1000 125–1000 (R)-(−)-Carvone 62.5 125 31.3 62.5 15.6–125 31.3–125 Dihydrocarvone (E + Z) 125 125 500 1000 125–1000 125–1000 Metronidazole 31.3 31.3 7.8 31.3 1.95–250 7.8–250 * MIC—minimum inhibitory concentration, MBC—minimum bactericidal concentration, MIC50 and MIC90—the minimum concentration at which 50% and 90% of the isolates were inhibited, respectively. ..



    Similar Products

    mbc mic50 mic90 mic range mbc range mpall  (ATCC)
    96
    ATCC mbc mic50 mic90 mic range mbc range mpall
    Mbc Mic50 Mic90 Mic Range Mbc Range Mpall, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mic90+range/Auricularia+fuscosuccinea+(Montagne)+Farlow%2C+teleomorph/pm37570659-88-16-7
    Average 96 stars, based on 1 article reviews
    mbc mic50 mic90 mic range mbc range mpall - by Bioz Stars, 2026-10
    96/100 stars
    		  Buy from Supplier
    c time days n mic50 mic90 range  (ATCC)
    86
    ATCC c time days n mic50 mic90 range
    C Time Days N Mic50 Mic90 Range, supplied by ATCC, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mic90+range/Paenibacillus+polymyxa+phage+d/us10851401-353-8-83
    Average 86 stars, based on 1 article reviews
    c time days n mic50 mic90 range - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    activity against enterococcus spp strains range mic50 mic90 mode antimicrobial agent  (ATCC)
    95
    ATCC activity against enterococcus spp strains range mic50 mic90 mode antimicrobial agent
    Activity Against Enterococcus Spp Strains Range Mic50 Mic90 Mode Antimicrobial Agent, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mic90+range/Enterococcus+sp/us09725466-371-5-46
    Average 95 stars, based on 1 article reviews
    activity against enterococcus spp strains range mic50 mic90 mode antimicrobial agent - by Bioz Stars, 2026-10
    95/100 stars
    		  Buy from Supplier
    agents range mic50 mic90 ikmc cmc total range mic50 mic90 ikmc cmc total cst  (Cell Signaling Technology Inc)
    95
    Cell Signaling Technology Inc agents range mic50 mic90 ikmc cmc total range mic50 mic90 ikmc cmc total cst
    Agents Range Mic50 Mic90 Ikmc Cmc Total Range Mic50 Mic90 Ikmc Cmc Total Cst, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mic90+range/PHB1+Antibody/pm25029126-49-28-41
    Average 95 stars, based on 1 article reviews
    agents range mic50 mic90 ikmc cmc total range mic50 mic90 ikmc cmc total cst - by Bioz Stars, 2026-10
    95/100 stars
    		  Buy from Supplier
    mic mfc mic50 mic90 range mfc50 mfc90 range xanthorrhizol c albicans atcc  (ATCC)
    94
    ATCC mic mfc mic50 mic90 range mfc50 mfc90 range xanthorrhizol c albicans atcc
    Mic Mfc Mic50 Mic90 Range Mfc50 Mfc90 Range Xanthorrhizol C Albicans Atcc, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mic90+range/Mycobacterium+gastri+Wayne/pm16617064-96-4-14
    Average 94 stars, based on 1 article reviews
    mic mfc mic50 mic90 range mfc50 mfc90 range xanthorrhizol c albicans atcc - by Bioz Stars, 2026-10
    94/100 stars
    		  Buy from Supplier
    main components against candida albicans substance c albicans strain mic mfc mic9 sd mic50 mic90 range mfc9 sd mfc50 mfc90 range lavender oil op  (ATCC)
    96
    ATCC main components against candida albicans substance c albicans strain mic mfc mic9 sd mic50 mic90 range mfc9 sd mfc50 mfc90 range lavender oil op
    Main Components Against Candida Albicans Substance C Albicans Strain Mic Mfc Mic9 Sd Mic50 Mic90 Range Mfc9 Sd Mfc50 Mfc90 Range Lavender Oil Op, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mic90+range/35%2E1/pm16178366-98-33-76
    Average 96 stars, based on 1 article reviews
    main components against candida albicans substance c albicans strain mic mfc mic9 sd mic50 mic90 range mfc9 sd mfc50 mfc90 range lavender oil op - by Bioz Stars, 2026-10
    96/100 stars
    		  Buy from Supplier
    influenzae method antibiotic range mg l mic50 mg l mic90 mg l mic mg l atcc 49247 etest nalidixic acid  (ATCC)
    96
    ATCC influenzae method antibiotic range mg l mic50 mg l mic90 mg l mic mg l atcc 49247 etest nalidixic acid
    Influenzae Method Antibiotic Range Mg L Mic50 Mg L Mic90 Mg L Mic Mg L Atcc 49247 Etest Nalidixic Acid, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mic90+range/Haemophilus+influenzae/pm12493800-57-12-22
    Average 96 stars, based on 1 article reviews
    influenzae method antibiotic range mg l mic50 mg l mic90 mg l mic mg l atcc 49247 etest nalidixic acid - by Bioz Stars, 2026-10
    96/100 stars
    		  Buy from Supplier
    vitro activity mg l mic mg l isogenic strains quinolonea mic50 mic90 range r6 r6n atcc 1n27 bms  (ATCC)
    93
    ATCC vitro activity mg l mic mg l isogenic strains quinolonea mic50 mic90 range r6 r6n atcc 1n27 bms
    Vitro Activity Mg L Mic Mg L Isogenic Strains Quinolonea Mic50 Mic90 Range R6 R6n Atcc 1n27 Bms, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mic90+range/Candida+parapsilosis+(Ashford)+Langeron+et+Talice/pm11533016-31-1-14
    Average 93 stars, based on 1 article reviews
    vitro activity mg l mic mg l isogenic strains quinolonea mic50 mic90 range r6 r6n atcc 1n27 bms - by Bioz Stars, 2026-10
    93/100 stars
    		  Buy from Supplier

    Image Search Results